Sensitivity Training for Parents With Premature Infants

April 19, 2022 updated by: The University of Hong Kong

Sensitivity Training for Mothers With Premature Infants: A Randomized Controlled Trial

This study evaluated the effectiveness of a culturally adapted version of the Mother-Infant Transaction Program (MITP) among Chinese mothers with premature infants in public hospitals in Hong Kong.

Study Overview

Detailed Description

Potential participants at two public hospitals in Hong Kong were identified by ward nurses. Mother-infant dyads with infants born at 36 weeks or earlier were assessed for eligibility. Data collection was conducted after obtaining written consent from the mothers. Mother-infant dyads who met the inclusion criteria were randomly allocated to either the intervention or the treatment-as-usual control group. Each dyad was assessed at six time points, i.e., baseline, immediately after intervention/TAU, and when the infants were at the gestation-corrected ages of 3, 6, 9, and 12 months.

Study Type

Interventional

Enrollment (Actual)

68

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Hong Kong, Hong Kong
        • University of Hong Kong

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  • Mothers with premature infants born at 36 weeks or earlier

Exclusion Criteria:

  • insufficient spoken and written Chinese ability of the mother
  • mother under 18 years of age
  • triplets or higher multiples
  • infants with congenital abnormalities (e.g., metabolic disorder, chromosomal disorder)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: SUPPORTIVE_CARE
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: SINGLE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
EXPERIMENTAL: Mother-Infant Transaction Program
Four sessions were delivered to the mothers one-on-one based on a manualized protocol while the infants were still in the neonatal intensive care units. These coaching sessions included psychological care for the mother and topics on recognizing premature infant's characteristics, understanding and recognizing signs of infant stress and infant's engagement and disengagement cues, principles of graded stimulation, and how to optimize interactions and avoid over-stimulating the infant.
Parent sensitivity training for mothers of premature infants
ACTIVE_COMPARATOR: Treatment as usual
For this group, infants and mothers received standard hospital care following the initial baseline assessment; these mothers were invited to ask questions about recommended ways to take care of their infants, but no specific knowledge or skills targeted by the adapted MITP program were taught
Standard hospital care and parental support

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Behavioral observation of mother-infant interactions
Time Frame: At baseline prior to intervention
Maternal sensitivity and quality of mother-infant interaction measured by coding a 5-min video of mother-infant interaction. The coded variables are rated on a 5-point scale, and higher scores indicate higher maternal sensitivity and better interaction quality.
At baseline prior to intervention
Behavioral observation of mother-infant interactions
Time Frame: Immediately after intervention
Maternal sensitivity and quality of mother-infant interaction measured by coding a 5-min video of mother-infant interaction. The coded variables are rated on a 5-point scale, and higher scores indicate higher maternal sensitivity and better interaction quality.
Immediately after intervention
Behavioral observation of mother-infant interactions
Time Frame: At infant's corrected age of 3 months
Maternal sensitivity and quality of mother-infant interaction measured by coding a 5-min video of mother-infant interaction. The coded variables are rated on a 5-point scale, and higher scores indicate higher maternal sensitivity and better interaction quality.
At infant's corrected age of 3 months
Behavioral observation of mother-infant interactions
Time Frame: At infant's corrected age of 6 months
Maternal sensitivity and quality of mother-infant interaction measured by coding a 5-min video of mother-infant interaction. The coded variables are rated on a 5-point scale, and higher scores indicate higher maternal sensitivity and better interaction quality.
At infant's corrected age of 6 months
Maternal postnatal depression
Time Frame: At baseline prior to intervention
Maternal depression measured by the Edinburgh Postnatal Depression Scale. Possible scores range from 0 to 30. Higher scores indicate higher levels of depression.
At baseline prior to intervention
Maternal postnatal depression
Time Frame: Immediately after intervention
Maternal depression measured by the Edinburgh Postnatal Depression Scale. Possible scores range from 0 to 30. Higher scores indicate higher levels of depression.
Immediately after intervention
Maternal postnatal depression
Time Frame: At infant's corrected age of 3 months
Maternal depression measured by the Edinburgh Postnatal Depression Scale. Possible scores range from 0 to 30. Higher scores indicate higher levels of depression.
At infant's corrected age of 3 months
Maternal postnatal depression
Time Frame: At infant's corrected age of 6 months
Maternal depression measured by the Edinburgh Postnatal Depression Scale. Possible scores range from 0 to 30. Higher scores indicate higher levels of depression.
At infant's corrected age of 6 months
Parenting stress
Time Frame: At baseline prior to intervention
Parenting stress measured by the Parenting Stress Index-Short Form. Possible scores range from 36 to 180. Higher scores indicate higher levels of parenting stress.
At baseline prior to intervention
Parenting stress
Time Frame: Immediately after intervention
Parenting stress measured by the Parenting Stress Index-Short Form. Possible scores range from 36 to 180. Higher scores indicate higher levels of parenting stress.
Immediately after intervention
Parenting stress
Time Frame: At infant's corrected age of 3 months
Parenting stress measured by the Parenting Stress Index-Short Form. Possible scores range from 36 to 180. Higher scores indicate higher levels of parenting stress.
At infant's corrected age of 3 months
Parenting stress
Time Frame: At infant's corrected age of 6 months
Parenting stress measured by the Parenting Stress Index-Short Form. Possible scores range from 36 to 180. Higher scores indicate higher levels of parenting stress.
At infant's corrected age of 6 months
Infant's temperament
Time Frame: At baseline prior to intervention
Infant's soothability based on the Infant Behavior Questionnaire. A higher average score denotes higher soothability of the infant, and the highest possible score is 7.
At baseline prior to intervention
Infant's temperament
Time Frame: Immediately after intervention
Infant's soothability based on the Infant Behavior Questionnaire. A higher average score denotes higher soothability of the infant, and the highest possible score is 7.
Immediately after intervention
Infant's temperament
Time Frame: At infant's corrected age of 3 months
Infant's soothability based on the Infant Behavior Questionnaire. A higher average score denotes higher soothability of the infant, and the highest possible score is 7.
At infant's corrected age of 3 months
Infant's temperament
Time Frame: At infant's corrected age of 6 months
Infant's soothability based on the Infant Behavior Questionnaire. A higher average score denotes higher soothability of the infant, and the highest possible score is 7.
At infant's corrected age of 6 months
Infant's weight gain
Time Frame: At infant's corrected age of 3 months
Infant's weight gain from birth
At infant's corrected age of 3 months
Infant's weight gain
Time Frame: At infant's corrected age of 6 months
Infant's weight gain from birth
At infant's corrected age of 6 months
Infant's weight gain
Time Frame: At infant's corrected age of 9 months
Infant's weight gain from birth
At infant's corrected age of 9 months
Infant's weight gain
Time Frame: At infant's corrected age of 12 months
Infant's weight gain from birth
At infant's corrected age of 12 months
Infant's developmental outcomes
Time Frame: At infant's corrected age of 3 months
Measured by the Cognitive Battery of the Merrill-Palmer-Revised Scales of Development, which includes assessments in the cognitive, receptive language, and fine motor domains. Higher scores denote better performance in the assessments
At infant's corrected age of 3 months
Infant's developmental outcomes
Time Frame: At infant's corrected age of 6 months
Measured by the Cognitive Battery of the Merrill-Palmer-Revised Scales of Development, which includes assessments in the cognitive, receptive language, and fine motor domains. Higher scores denote better performance in the assessments
At infant's corrected age of 6 months
Infant's developmental outcomes
Time Frame: At infant's corrected age of 9 months
Measured by the Cognitive Battery of the Merrill-Palmer-Revised Scales of Development, which includes assessments in the cognitive, receptive language, and fine motor domains. Higher scores denote better performance in the assessments
At infant's corrected age of 9 months
Infant's developmental outcomes
Time Frame: At infant's corrected age of 12 months
Measured by the Cognitive Battery of the Merrill-Palmer-Revised Scales of Development, which includes assessments in the cognitive, receptive language, and fine motor domains. Higher scores denote better performance in the assessments
At infant's corrected age of 12 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Terry Au, PhD, The University of Hong Kong

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

February 1, 2018

Primary Completion (ACTUAL)

August 31, 2019

Study Completion (ACTUAL)

August 31, 2019

Study Registration Dates

First Submitted

May 5, 2020

First Submitted That Met QC Criteria

May 6, 2020

First Posted (ACTUAL)

May 12, 2020

Study Record Updates

Last Update Posted (ACTUAL)

April 27, 2022

Last Update Submitted That Met QC Criteria

April 19, 2022

Last Verified

May 1, 2020

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

Individual participant data that underlie the results reported in this article, after deidentification (text, tables, figures, and appendices)

IPD Sharing Time Frame

Beginning 9 months and ending 36 months following article publication.

IPD Sharing Access Criteria

Investigators whose proposed use of the data has been approved by an independent review committee identified for this purpose.

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Premature Birth

Clinical Trials on Mother-Infant Transaction Program

3
Subscribe